On Friday, I discussed American Intl Group (AIG), which showed significant distribution and poor relative strength within a very weak industry group. This morning, I want to highlight a company that appears to be under significant accumulation and is showing excellent relative strength within an industry group that's been leading U.S. equities higher. Regeneron Pharmaceuticals (REGN), a biotech company ($DJUSBT), has an accumulation/distribution line
that's been rising for months. REGN's relative strength has been rising for months as well: